s it pursues Mylan Pharmaceuticals for $100 million in taxes, the Internal Revenue Service is accusing the drug maker of bad faith in complying with ongoing requests to cough up documents needed for a looming trial.

In court documents filed last month, the IRS alleges that Mylan has “repeated false assurances and [offered] incomplete responses” to its efforts to obtain materials over the past two years. And the failure to produce the documents is “inexcusable,” the IRS wrote in a motion asking the US Tax Court to force the company to turn over emails, correspondence, and other paperwork (see here, here and here).

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.